Pancreatic Cancer Research

ResearcherUniversity of FreiburgActive in the last 2 years

Oliver Schilling

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-7678-7653; OpenAlex author ID A5050843400. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
48
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 12

  1. Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations. Co-author DOI 10.1038/s41392-025-02563-7↗
  2. Neoadjuvant chemo- or chemo-radiation-therapy of pancreatic ductal adenocarcinoma differentially shift ECM composition, complement activation, energy metabolis… Last author DOI 10.1002/ijc.34867↗
  3. Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pa… Last author DOI 10.1016/j.neo.2022.100871↗
  4. Overexpression of integrin alpha 2 (ITGA2) correlates with poor survival in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jclinpath-2022-208176↗
  5. Proteome alterations during clonal isolation of established human pancreatic cancer cell lines. Last author DOI 10.1007/s00018-022-04584-9↗
  6. Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis. Co-author DOI 10.3791/62541↗
  7. Neoplastic-Stromal Cell Cross-talk Regulates Matrisome Expression in Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-20-0439↗
  8. FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lines. Co-author DOI 10.21873/anticanres.14355↗
  9. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma. Last author DOI 10.1002/1878-0261.12426↗
  10. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer. Co-author DOI 10.1016/j.cell.2019.05.012↗
  11. Pregnancy Specific β-1 Glycoprotein 1 is Expressed in Pancreatic Ductal Adenocarcinoma and its Subcellular Localization Correlates with Overall Survival. Last author DOI 10.7150/jca.15864↗
  12. Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jgh.12752↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ulrich Friedrich Wellner · 7 shared papers, 2015–2023 · strength 0.62
  2. Tobias Keck · 4 shared papers, 2015–2023 · strength 0.41
  3. Kim C. Honselmann · 3 shared papers, 2020–2023 · strength 0.36
  4. Patrick Bernhard · 2 shared papers, 2022–2023 · strength 0.34
  5. Louisa Bolm · 2 shared papers, 2021–2023 · strength 0.28
  6. Rüdiger Braun · 2 shared papers, 2021–2023 · strength 0.28
  7. Steffen Deichmann · 2 shared papers, 2021–2023 · strength 0.28
  8. Andrew Scott Liss · 3 shared papers, 2019–2020 · strength 0.25
  9. Cristina Rosa Ferrone · 2 shared papers, 2020–2023 · strength 0.25
  10. Vikram Deshpande · 2 shared papers, 2019–2023 · strength 0.22
  11. Maren Nicole Stillger · 1 shared paper, 2024 · strength 0.22
  12. Sylvia Timme‐Bronsert · 1 shared paper, 2024 · strength 0.22
  13. Friederike Inga Nollmann · 1 shared paper, 2026 · strength 0.20
  14. Melanie Boerries · 1 shared paper, 2026 · strength 0.20
  15. Wilfried Reichardt · 1 shared paper, 2026 · strength 0.20
  16. Asma Y. Alrawashdeh · 1 shared paper, 2026 · strength 0.20
  17. Philipp Hafner · 1 shared paper, 2026 · strength 0.20
  18. Dietrich Alexander Ruess · 1 shared paper, 2026 · strength 0.20
  19. Uwe A. Wittel · 1 shared paper, 2026 · strength 0.20
  20. Carlos F. Fernandez-del Castillo · 2 shared papers, 2020 · strength 0.19
  21. Andrew Louis Warshaw · 2 shared papers, 2020 · strength 0.19
  22. Sebastian K.S. Begg · 2 shared papers, 2020 · strength 0.19
  23. David Jérémie Birnbaum · 2 shared papers, 2020 · strength 0.19
  24. Mari A. Mino-Kenudson · 2 shared papers, 2020 · strength 0.19
  25. Keith D. Lillemoe · 2 shared papers, 2020 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.